Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fulcrum Therapeutics Inc (NQ: FULC )

7.950 -0.270 (-3.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 23, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 245,652
Open 8.100
Bid (Size) 7.000 (1)
Ask (Size) 9.920 (1)
Prev. Close 8.220
Today's Range 7.610 - 8.110
52wk Range 3.210 - 29.12
Shares Outstanding 41,009,442
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
U.S. Stock Futures Edge Lower Ahead Of Walmart, Home Depot Earnings
Pre-open movers 
Via Benzinga
Walmart, Home Depot And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading slightly lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga

Performance

YTD
-55.39%
-55.39%
1 Month
-1.12%
-1.12%
3 Month
+54.67%
+54.67%
6 Month
-61.22%
-61.22%
1 Year
-70.27%
-70.27%

More News

Read More
Recap: Fulcrum Therapeutics Q2 Earnings
Via Benzinga
Fulcrum Therapeutics Earnings Preview
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
4 Analysts Have This to Say About Fulcrum Therapeutics
Via Benzinga
Analyst Ratings for Fulcrum Therapeutics
Via Benzinga
Recap: Fulcrum Therapeutics Q1 Earnings
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
10 Biggest Price Target Changes For Monday
Via Benzinga
Mid-Afternoon Market Update: Dow Drops Over 600 Points; Fulcrum Therapeutics Shares Tumble
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
91 Biggest Movers From Friday
Via Benzinga
Mid-Day Market Update: Nasdaq Dips 400 Points; Cogent Biosciences Shares Jump
Via Benzinga
44 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; US Inflation Rate Accelerates to 8.6%
Via Benzinga
Looking Into Fulcrum Therapeutics's Return On Capital Employed
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Earnings Preview: Fulcrum Therapeutics
Via Benzinga
Fulcrum Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
Via Benzinga
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
Via Benzinga
Fulcrum Therapeutics's Return On Capital Employed Overview
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.